Results 271 to 280 of about 26,709,678 (285)

Progress in COX-2 inhibitors: a journey so far.

Current Medicinal Chemistry, 2010
A. Chakraborti, Sanjeev K. Garg, Raj Kumar, Hashim F Motiwala, Pradeep S. Jadhavar   +4 more
semanticscholar   +1 more source

COX-2 selective inhibitors: analysis of the renal effects

Expert Opinion on Drug Safety, 2002
Mark A Perazella
exaly  

Antinociception and the New COX Inhibitors: Research Approaches and Clinical Perspectives

CNS Neuroscience & Therapeutics, 2003
Juan F Herrero, Gema Gaitan
exaly  

COX-2 inhibitors, other NSAIDs, and cardiovascular risk: the seduction of common sense.

Journal of the American Medical Association (JAMA), 2006
D. Graham
semanticscholar   +1 more source

Synthesis and biological evaluation of N-substituted-3,5-diphenyl-2-pyrazoline derivatives as cyclooxygenase (COX-2) inhibitors

European Journal of Medicinal Chemistry, 2010
Francesco Ortuso, Roberto Cirilli, Stefano Alcaro   +2 more
exaly  

COX-2 inhibitors--lessons in drug safety.

New England Journal of Medicine, 2005
B. Psaty, C. Furberg
semanticscholar   +1 more source

A pan-tumor review of the role of poly(adenosine diphosphate ribose) polymerase inhibitors

Ca-A Cancer Journal for Clinicians
Talia Golan, Jennifer K Litton, Nicolas Sayegh   +2 more
exaly  

Novel 2-(4-methylsulfonylphenyl)pyrimidine derivatives as highly potent and specific COX-2 inhibitors

Bioorganic and Medicinal Chemistry, 2008
Roberto Olivera, Aurelio Orjales
exaly  

A systematic review of COX‐2 inhibitors compared with traditional NSAIDs, or different COX‐2 inhibitors for post‐operative pain

Acta Anaesthesiologica Scandinavica, 2004
J. Rømsing, S. Møiniche
semanticscholar   +1 more source

What is the harm-benefit ratio of Cox-2 inhibitors?

International Journal of Epidemiology, 2008
Tjeerd P van Staa, H G M Leufkens
exaly